Amylyx Pharmaceuticals, Inc.: Amylyx Pharmaceuticals Submits

Amylyx Pharmaceuticals, Inc. today announced it has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP)

Related Keywords

Canada , Phoenix , Arizona , United States , Becky Gohsler , Seanm Healey , Kostenloser Wertpapierhandel , Amylyx Pharmaceuticals Inc , Leandrop Rizzuto Foundation , Amylyx Pharmaceuticals , Exchange Commission , European Union , European Medicines Agency , Committee For Medicinal Products Human Use , Marketing Authorization Application , Medicinal Products , Human Use , Rating Scale , New England Journal , Application Reviews , Rating Scale Revised , Bucket Challenge , Amylyx Phase , United States Securities , Amylyx , Pharmaceuticals , Ubmits , Marketing , Authorization , Application , Mx0035 , Treatment ,